DLX4 also induced the expression of CD44 in ovarian cancer cells, and inhibition of CD44 abolished DLX4′s ability of DLX4 to promote tumor-mesothelial cell interactions in these cells [81]. This evidence concerns the gene CD44 and ovarian cancer.